Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q42761047)
Watch
English
Acetylcholinesterase inhibitors for Alzheimer's disease
scientific article published on March 1999
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
editorial
0 references
title
Acetylcholinesterase inhibitors for Alzheimer's disease
(English)
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
main subject
Alzheimer's disease
0 references
author name string
Flicker L
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
language of work or name
English
0 references
publication date
1 March 1999
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
published in
The BMJ
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
volume
318
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
issue
7184
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
page(s)
615-616
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
cites work
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1115069
retrieved
27 May 2018
Cholinesterase inhibition for Alzheimer disease: a meta-analysis of the tacrine trials. Dementia Trialists' Collaboration
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1115069
retrieved
27 May 2018
New drug treatment for Alzheimer's disease: lessons for healthcare policy
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1115069
retrieved
27 May 2018
The International Working Group on Harmonization of Dementia Drug Guidelines: past, present, and future.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1115069
retrieved
27 May 2018
Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1115069
retrieved
27 May 2018
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1115069
retrieved
16 August 2018
Heterogeneity of adverse hepatic reactions to tetrahydroaminoacridine
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1115069
retrieved
16 August 2018
Identifiers
DOI
10.1136/BMJ.318.7184.615
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
PMCID
1115069
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
PubMed ID
10066180
1 reference
stated in
Europe PubMed Central
PMCID
1115069
retrieved
6 November 2017
ResearchGate publication ID
13224911
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
